host reads [15, 20] aligning to the human fraction of the National Center for 2 0 3 Biotechnology Information (NCBI) nucleotide collection database (NT database, 2 0 4 downloaded March 2015) at word size 11 and e-value cutoff of 10 -5 . On our 64 2 0 5 core machine, the remaining, non-human reads are then aligned by BLASTn to 2 0 6 the entire NCBI nt database using the same parameters. On a laptop, the non-2 0 7 human reads are aligned to the viral fraction of the NCBI nt database. Reads 2 0 8 that hit this viral database are then aligned by BLASTn to NCBI nt. For each 2 0 9 read, the single best hit by e-value is retained. The NCBI GenBank gene 2 1 0 identifier assigned to the best hit is then annotated by taxonomic lookup of the 2 1 1 corresponding lineage, family, genus, and species [15] .
1 2
For real-time visualization of results, a graphical user interface was 2 1 3 developed for the MetaPORE pipeline. A "live" taxonomic count table is 2 1 4 displayed as a donut chart using the CanvasJS (http://canvasjs.com) graphics 2 1 5 suite, with the chart refreshing every 30 sec (Supplementary Data, Movie 1). For 2 1 6 each viral family, genus, and species, the "top hit" is chosen to be the reference 2 1 7 sequence with the greatest number of aligned reads, with priority given to 2 1 8 reference sequences in the following order: (1) complete genomes; (2) representative members of the Asian-Pacific clade, was also analyzed ( Fig. 2E ).
3 9
The EBOV phylogeny ( Fig. 3E To test the ability of nanopore sequencing to identify metagenomic 2 5 0 reads from a clinical sample, we first analyzed a plasma sample harboring high- Rico (strain PR-S6), with a calculated viral titer of 9.1x10 7 copies/mL.
5 5
A read aligning to CHIKV, the 96th read, was sequenced within 6 min 2 5 6 Our previous experiments revealed both the total number of 3 1 2 metagenomic reads and proportion of target viral reads at a given titer that could 3 1 3 be obtained from a single MinION flowcell, and showed that the proportion of 3 1 4 viral reads obtained by metagenomic nanopore and MiSeq sequencing was 3 1 5 comparable. Thus, we projected that the minimum concentration of virus that 3 1 6 could be reproducibly detected using our current metagenomic protocol would be 3 1 7 1x10 5 copies/mL. An HCV-positive clinical sample (HepC1) was diluted in 3 1 8 negative control serum matrix to a titer of 1x10 5 copies/mL and processed for 3 1 9 nanopore sequencing using an upgraded library preparation kit (MAP-004). After 3 2 0 four consecutive runs on the same flowcell with repeat loading of the same 3 2 1 metagenomic HepC1 library (Fig. 3A) , a total of 85,647 reads were generated, of 3 2 2 which only 6 (0.0070%) aligned to HCV (Fig. 3B ). Although the entire series of HCV reads in the nanopore data, the vast majority (96%) of viral sequences 3 2 7 identified corresponded to the background lambda phage spike-in. Importantly, 3 2 8 although only 6 HCV reads were identified by nanopore sequencing, all 6 reads 3 2 9
aligned to the correct genotype, genotype 1b ( Fig. 3D ). answer turnaround times, and potentially yields quantitative information. Notably, 3 9 0 our nanopore data suggest that very few reads are needed to provide an 3 9 1 unambiguous diagnostic identification, despite high individual per read error rates 3 9 2 of 10-30%. The ability of nanopore sequence analysis to accurate identify 3 9 3 viruses to the species and even strain / genotype level is facilitated by the high 3 9 4 specificity of sequence data, especially with the longer target viral reads 3 9 5 achievable by nanopore (Table 1 , 391 bp average length) versus second-3 9 6 generation sequencing.
9 7
Although the overall turnaround time from metagenomic sample-to-3 9 8 detection has been reduced to <6 hr, many challenges remain for routine 3 9 9 implementation of this technology in clinical and public health settings.
0 0
Improvements to make library preparation faster and more robust are critical, 4 0 1 including automation and optimization of each step in the protocol. We also 4 0 2 looked only at clinical samples at moderate to high titers of 10 5 -10 8 copies / mL, (556) Chikungunya virus (7) Phages (15) Ebola2-MiSeq Viruses
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